« previous next »
Pages: [1]

Author Topic: (Abst.) Comparing the risk of serious infections in patients with and without MS...  (Read 20 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9843
  • MS diagnosed 1980
  • Location: Pacific Northwest
(Abst.) Comparing the risk of serious infections in patients with and without MS...
« on: March 12, 2023, 11:39:50 am »
From PubMed (March 12, 2023)--"Comparing the risk of serious infections in patients with and without MS: A German claims data analysis":


https://pubmed.ncbi.nlm.nih.gov/36905817/


Just what is meant by a "serious infection" isn't clear in the abstract but it may mean an infection serious enough to necessitate hospitalization.
« Last Edit: March 12, 2023, 11:41:26 am by agate »
Report to moderator   Logged
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20 - 3/16/24.
Pages: [1]
« previous next »
 

Related Topics

  Subject / Started by Replies Last post
0 Replies
118 Views 		Last post September 26, 2017, 03:41:45 pm
by agate
0 Replies
114 Views 		Last post October 06, 2018, 03:49:31 pm
by agate
0 Replies
44 Views 		Last post August 02, 2020, 01:43:53 pm
by agate
0 Replies
38 Views 		Last post March 12, 2021, 09:18:44 pm
by agate
0 Replies
9 Views 		Last post June 15, 2023, 08:59:00 pm
by agate